AnalystsRoy Buchanan
Roy Buchanan's Stock Forecasts

Analyst Ranking
Bottom 5%
#4720 out of 4929 analysts
Average Return
-9.39%
Win Rate
37%25 out of 67
Risk vs Reward
Poor
Good

Roy Buchanan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Cidara Therapeutics IncCDTX
+161.84%$18.63$48.78
2025-05-08 -
2025-07-03
Buy
Cidara Therapeutics IncCDTX
+130.97%$21.12$48.78
2025-04-28 -
2025-07-03
Buy
Cidara Therapeutics IncCDTX
+115.22%$22.67$48.78
2025-06-01 -
2025-07-03
Buy
Cidara Therapeutics IncCDTX
+112.09%$23.00$48.78
2025-03-11 -
2025-07-03
Buy
Cidara Therapeutics IncCDTX
+103.25%$24.00$48.78
2025-05-26 -
2025-07-03
Buy

Roy Buchanan Analyst Color

Get additional color on Roy Buchanan's coverage of popular stocks

Roy Buchanan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cidara Therapeutics IncCDTX
6Buy$59.00+20.95%Maintains
4 days ago
Polypid LtdPYPD
2Buy$14.00+300.00%Maintains
17 days ago
Enanta Pharmaceuticals IncENTA
12Buy$24.00+204.18%Maintains
a month ago
Curevac NvCVAC
9Buy$10.00+83.49%Reiterates
a month ago
Dynavax Technologies CorpDVAX
6Buy$31.00+201.85%Maintains
2 months ago
An2 Therapeutics IncANTX
8Buy$2.00+90.48%Maintains
2 months ago
Inovio Pharmaceuticals IncINO
3Buy$18.00+1,253.38%Reiterates
4 months ago
Esperion Therapeutics IncESPR
3Buy$4.00+241.88%Reiterates
5 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$14.00+1,727.68%Maintains
5 months ago
Abivax SaABVX
1Buy$33.00+314.57%Reiterates
6 months ago
Hookipa Pharma IncHOOK
2Buy$7.00+469.11%Maintains
7 months ago
Gritstone Bio IncGRTSQ
4Buy$5.00+15,525.00%Reiterates
a year ago
Arbutus Biopharma CorpABUS
5Buy$5.00+54.32%Maintains
a year ago
Pardes Biosciences IncPRDS
2Buy$5.00N/AMaintains
2 years ago
Argenx SeARGX
2Buy$448.00N/AMaintains
2 years ago
Cormedix IncCRMD
1Hold$16.00N/AMaintains
2 years ago
Ibio IncIBIO
1Buy$750.00N/AInitiates Coverage On
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.